The effect of prenatal methylmercury administration on postnatal renal functional development.
In utero exposure of rats to methylmercury has been reported to produce degenerative and hyperplastic changes in renal proximal and distal tubules, although no assessment of postnatal renal functional capacity was made. CH3HgCl was administered ip to Sprague-Dawley rats on Day 8 of gestation at 4 or 6 mg Hg/kg or on Days 8, 10, and 12 at 4 mg Hg/kg (3 x 4 mg Hg/kg). These doses produced no overt toxicological effects nor had any effect on litter size, body weight, or kidney weight to body weight ratios. The concentration of mercury in kidneys, liver, and brain at 1 and 7 days postpartum was dose-related but was not detectable at 42 days. In vitro renal function was assessed in renal cortical slices from rats at 1, 7, and 42 days postpartum by determining the ability to accumulate organic ions and to generate glucose. Additionally, parameters of in vivo renal function were determined in normopenic, hydropenic (5 pressor units/kg ADH, sc, 18 hr water deprived), and in volume-loaded male rats at 42 days postpartum. At 42 days postpartum in the 3 x 4 mg Hg/kg treatment group, p-aminohippurate accumulation was depressed slightly as was the ability to eliminate Na+ and water in volume-loaded rats. These data suggest that postnatal renal physiological sequelae to prenatal administration of methylmercury may be less than predicted from histological studies.
D000818:Animals; D001923:Brain Chemistry; D005260:Female; D005333:Fetus / Q000187:drug effects; D066298:In Vitro Techniques; D007668:Kidney / Q000032:analysis / Q000187:drug effects* / Q000503:physiopathology; D008099:Liver / Q000032:analysis; D008628:Mercury / Q000032:analysis; D008767:Methylmercury Compounds / Q000633:toxicity*; D011247:Pregnancy; D011297:Prenatal Exposure Delayed Effects; D051381:Rats; D011919:Rats, Inbred Strains
D008767:Methylmercury Compounds; D008628:Mercury